XCR1 and neoplasm: Comparing sham-operated and tumor-bearing mice at D28, we observed significant increases in T lymphocytes (three-fold increase), natural-killer cells and in all DC subpopulations (XCR1+ DCs, CD11b+ DCs and plasmacytoid DCs, monocyte-derived DC P2 and P3 as well as in their precursor P1).